Who’s Watching Your Supply Chain? Strategies for Mitigating Risk in Clinical Trials


With the ever increasing costs of clinical trials and the advantages of being first-to-market, it’s time to take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within your budget. Unfortunately, many new and emerging biopharmas may not have the required capabilities in house to meet the challenges.

This whitepaper will help guide you through the numerous considerations necessary for you to decide whether to build your capability, outsource it, or create a hybrid in-source/out-source model.